High levels of HMGB1 have been detected in ST/SF of RA and JIA patients and shown to correlate with early disease onset/activity (90, 155) and contribute to bone remodeling (156), representing an inflammatory marker and potential therapeutic target (155, 157). Here, HMGB1 is linked to rheumatoid arthritis.